Protective effect of thioredoxin perfusion but not inhalation in warm ischemic-reperfused rat lungs

References

• Holmgren A. Thioredoxin. Annu Rev Biochem 1985; 54: 237–271.
   PubMed Web of Science ®Google Scholar
• Nakamura H. Thioredoxin and its related molecules: update 2005. Antioxid Redox Signal 2005; 7: 823–828.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nakamura H, Hoshino T, Ueda S, Wada H, Yodoi J. Redox regulation of lung inflammation by thioredoxin. Ant ioxid Redox Signal 2005; 7: 60–71.
   PubMed Web of Science ®Google Scholar
• Kondo N, Ishii Y, Kwon YW et al. Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol 2004; 172: 442–448.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immuno11997; 15: 351-369.
   Google Scholar
• Bertini R, Howard OM, Dong HF et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med 1999; 189: 1783–1789.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Herzenberg LA, Bai Jet al. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Nat! Acad Sci USA 2001; 98: 15143–15148.
   PubMed Web of Science ®Google Scholar
• Duncan SR. In: Norman DJ, Turka LA. (eds) Primer on transplantation, 2nd edn. Philadelphia, PA: American Society of Transplantation, 2001; 685-695.
   Google Scholar
• Mora BN, Patterson GA. In: Baumgartner WA, Kasper E, Reitz B, Theodore J. (eds) Heart and lung transplantation, 2nd edn. Philadelphia, PA: WB Saunders, 2002; 142-154.
   Google Scholar
• Fukuse T, Hirata T, Yokomise H et al. Attenuation of ischaemia reperfusion injury by human thioredoxin. Thorax 1995; 50: 387–391.
   PubMed Web of Science ®Google Scholar
• Yokomise H, Fukuse T, Hirata T et al. Effect of recombinant human adult T cell leukemia-derived factor on rat lung reperfusion injury. Respiration 1994; 61: 99–104.
   PubMed Web of Science ®Google Scholar
• Okubo K, Kosaka S, Isowa Net al. Amelioration of ischemia reperfusion injury by human thioredoxin in rabbit lung. J Thorac Cardiovasc Surg 1997; 113: 1–9.
   PubMed Web of Science ®Google Scholar
• Yagi K, Liu C, Bando T et al. Inhibition of reperfusion injury by human thioredoxin (adult T-cell leukemia-derived factor) in canine lung transplantation. J Thorac Cardiovasc Surg 1994; 108: 913–921.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Hoshino Y, Yamada A et al. Recombinant human thioredoxin-1 becomes oxidized in circulation and suppresses bleomycin-induced neutrophil recruitment in the rat airway. Free Radic Res 2007; 41: 1089–1098.
   PubMed Web of Science ®Google Scholar
• Mitsui A, Hirakawa H, Yodoi J. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem Biophys Res Commun 1992; 186: 1220–1226.
   PubMed Web of Science ®Google Scholar
• Chen F, Nakamura T, Fujinaga T et al. Protective effect of a nebulized beta(2)-adrenoreceptor agonist in warm ischemic-reperfused rat lungs. Ann Thorac Surg 2006; 82: 465–471.
   PubMed Web of Science ®Google Scholar
• Fujinaga T, Nakamura T, Fukuse T et al. Isoflurane inhalation after circulatory arrest protects against warm ischemia reperfusion injury of the lungs. Transplantation 2006; 82: 1168–1174.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Abu-Dahab R, Menger MD et al. Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung. J Heart Lung Transplant 2005; 24: 38–45.
   PubMed Web of Science ®Google Scholar
• Ueda S, Nakamura T, Yamada Act al. Recombinant human thioredoxin suppresses lipopolysaccharide-induced bronchoalveolar neutrophil infiltration in rat. Life Sci 2006; 79: 1170–1177.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Suda K, Imai H, Era S. Simple and sensitive high-performance liquid chromatographic method for the investigation of dynamic changes in the redox state of rat serum albumin. J Chromatogr B 2002; 772: 139–146.
   PubMed Web of Science ®Google Scholar
• Takagi Y, Mitsui A, Nishiyama A et al. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA 1999; 96: 4131–4136.
   PubMed Web of Science ®Google Scholar
• Takagi Y, Tokime T, Nozaki K, Gon Y, Kikuchi H, Yodoi J. Redox control of neuronal damage during brain ischemia after middle cerebral artery occlusion in the rat: immunohistochemical and hybridization studies of thioredoxin. J Cereb Blood Flow Metab 1998; 18: 206–214.
   PubMed Web of Science ®Google Scholar
• Nakamura H, De Rosa S, Roederer M et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 1996; 8: 603–611.
   PubMed Web of Science ®Google Scholar
• Ahsan MK, Nakamura H, Tanito M, Yamada K, Utsumi H, Yodoi J. Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt. Free Radic Rio! Med 2005; 39: 1549–1559.
   PubMed Web of Science ®Google Scholar
• Wada H, Hirata T, Decampos KN, Hitomi S, Slutsky AS. Effect of the combination of human thioredoxin and L-cysteine on ischemia-reperfusion injury in isolated rat lungs. Eur Surg Res 1995; 27: 363–370.
   PubMed Web of Science ®Google Scholar
• Gasdaska JR, Kirkpatrick DL, Montfort W et al. Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73->Ser mutation. Biochem Pharmaco11996; 52: 1741-1747.
   Google Scholar
• Weichsel A, Gasdaska JR, Powis G, Montfort WR. Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure 1996; 4: 735–751.
   PubMed Web of Science ®Google Scholar
• Andersen JF, Sanders DA, Gasdaska JR, Weichsel A, Powis G, Montfort WR. Human thioredoxin homodimers: regulation by pH, role of aspartate 60, and crystal structure of the aspartate 60->asparagine mutant. Biochemistry 1997; 36: 13979–13988.
   PubMed Web of Science ®Google Scholar
• Ren X, Bjornstedt M, Shen B, Ericson ML, Holingren A. Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. Biochemistry 1993; 32: 9701–9708.
   PubMed Web of Science ®Google Scholar
• Tamaki H, Nakamura H, Nishio Act al. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology 2006; 131: 1110–1121.
   PubMed Web of Science ®Google Scholar
• Amaral FA, Fagundes CT, Guabiraba R et al. The role of macrophage migration inhibitory factor in the cascade of events leading to reperfusion-induced inflammatory injury and lethality. Am J Pathol 2007; 171: 1887–1893.
   PubMed Web of Science ®Google Scholar
• Inomata Y, Tanihara H, Tanito M et al. Thioredoxin-1 suppresses choroidal neovascularization via interaction with complement factor H. Invest Ophthalmol Vis Sci 2008; 49: 5118–5125.
   PubMed Web of Science ®Google Scholar
• Le Brun PP, de Boer AH, Heijerman HG, Frijlink HW. A review of the technical aspects of drug nebulization. Pharm World Sci 2000; 22: 75–81.
   PubMed Web of Science ®Google Scholar